DUSA Pharmaceuticals: Independent Investigator Reports Complete Clearing Of Recalcitrant Inflammatory Acne Using Levulan’R’ Photodynamic Therapy With A Pulsed Dye Laser

DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA), is pleased to report the presentation of an independent investigator study in which complete clearance of facial acne was observed in 14/14 patients (100%) treated with the combination of Levulan® (aminolevulinic acid HCl, ALA) and long pulsed, pulsed dye laser for photodynamic therapy (PDT) for recalcitrant inflammatory acne vulgaris of the face.